Effects of sevoflurane on leucine-rich repeat kinase 2-associated Drosophila model of Parkinson's disease

Shan,Zhiming; Cai,Song; Zhang,Tao; Kuang,Liting; Wang,Qi; Xiu,Huanhuan; Wen,Jing; Gu,Huaiyu; Xu,Kangqing

doi:10.3892/mmr.2014.2966

Effects of sevoflurane on leucine-rich repeat kinase 2-associated Drosophila model of Parkinson's disease

Authors:
- Zhiming Shan
- Song Cai
- Tao Zhang
- Liting Kuang
- Qi Wang
- Huanhuan Xiu
- Jing Wen
- Huaiyu Gu
- Kangqing Xu
View Affiliations

Affiliations: Department of Anesthesiology, The First Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Anatomy and Neurobiology, Zhongshan School of Medicine, Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China
Published online on: November 18, 2014 https://doi.org/10.3892/mmr.2014.2966
Pages: 2062-2070

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Patients with Parkinson's disease (PD) often require surgery, and therefore may receive inhalation anesthesia. However, it is currently unknown whether inhalation anesthetics affect the prognosis of the disease. Leucine‑rich repeat kinase 2 (LRRK2) genetic mutations are the most common cause of familial PD, contributing to ~39% of all cases in certain populations. The aim of the present study was to determine the effects of inhaled anesthetics on PD, by observing the influence of sevoflurane on a LRRK2‑associated Drosophila model of PD. PD transgenic Drosophila overexpressing LRRK2 were generated by crossing flies expressing an LRRK2 upstream activation sequence, with tyrosine hydroxylase (TH)‑Gal4 flies. Western blot analysis successfully verified that the transgenic Drosophila overexpressed LRRK2. Three days prior to eclosion, three genotypes of Drosophila were divided into four groups, and were exposed to air, 1, 2, or 3% sevoflurane, for 5 hours. Twenty‑four hours after the exposure, the electrophysiological activities of the projection neurons (PN) in the brains of the Drosophila were recorded using a patch clamp. The locomotor activities were tested on days 5, 10, 15, 20, 25, 30, 35 and 40 following eclosion. The frequency of miniature excitatory synaptic currents (mEPSCs) obtained from the PNs of the TH‑wild type LRRK2 (TH‑WT) Drosophila brain, following exposure to air (1.60±0.05 Hz), was lower as compared with the wild type LRRK2 (WT) (2.51±0.07 Hz) and W1118 (2.41±0.10 Hz) Drosophila. After exposure to 1, 2 and 3% sevoflurane, the frequency of mEPSCs in the brains of the TH‑WT group decreased to 0.82±0.04 Hz, 0.63±0.16 Hz and 0.55±0.04 Hz, respectively. The percentage decrease of the frequency of mEPSCs, from exposure to air to 1% sevoflurane, of the TH‑WT group (48.32%±3.08%) was significantly higher, as compared with the WT (39.17%±1.42%) and W1118 (35.10%±2.66%) groups, and there was no statistical difference between the WT and W1118 groups. The transgenic TH‑WT Drosophila presented an early decrease in locomotor ability, as compared with the WT and W1118 groups. Following a 5 hour exposure to sevoflurane, the percentage decrease of the climbing abilities of the TH‑WT group, from exposure to air to 1% sevoflurane, were significantly lower, as compared with the WT and W1118 groups. In conclusion, sevoflurane had negative effects on the control W1118 flies, and also severely aggravated the prognosis of PD in the LRRK2‑associated Drosophila model, through synaptic cholinergic deficits and impairment on locomotor abilities.

View Figures

View References

1	Nicholson G, Pereira AC and Hall GM: Parkinson’s disease and anaesthesia. Br J Anaesth. 89:904–916. 2002. View Article : Google Scholar : PubMed/NCBI
2	Belin AC and Westerlund M: Parkinson’s disease: a genetic perspective. FEBS J. 275:1377–1383. 2008. View Article : Google Scholar : PubMed/NCBI
3	García-Pérez L, Linertová R, Lorenzo-Riera A, Vázquez-Díaz JR, Duque-González B and Sarría-Santamera A: Risk factors for hospital readmissions in elderly patients: a systematic review. QJM. 104:639–651. 2011. View Article : Google Scholar : PubMed/NCBI
4	Zhang X, Xue Z and Sun A: Subclinical concentration of sevoflurane potentiates neuronal apoptosis in the developing C57BL/6 mouse brain. Neurosci Lett. 447:109–114. 2008. View Article : Google Scholar : PubMed/NCBI
5	Culley DJ, Baxter MG, Yukhananov R and Crosby G: Long-term impairment of acquisition of a spatial memory task following isoflurane-nitrous oxide anesthesia in rats. Anesthesiology. 100:309–314. 2004. View Article : Google Scholar : PubMed/NCBI
6	Satomoto M, Satoh Y, Terui K, et al: Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology. 110:628–637. 2009. View Article : Google Scholar : PubMed/NCBI
7	Haseneder R, Kratzer S, von Meyer L, Eder M, Kochs E and Rammes G: Isoflurane and sevoflurane dose-dependently impair hippocampal long-term potentiation. Eur J Pharmacol. 623:47–51. 2009. View Article : Google Scholar : PubMed/NCBI
8	Ishizeki J, Nishikawa K, Kubo K, Saito S and Goto F: Amnestic concentrations of sevoflurane inhibit synaptic plasticity of hippocampal CA1 neurons through gamma-aminobutyric acid-mediated mechanisms. Anesthesiology. 108:447–456. 2008. View Article : Google Scholar : PubMed/NCBI
9	Mason LJ, Cojocaru TT and Cole DJ: Surgical intervention and anesthetic management of the patient with Parkinson’s disease. Int Anesth Clin. 34:133–150. 1996. View Article : Google Scholar
10	Ng M, Roorda RD, Lima SQ, Zemelman BV, Morcillo P and Miesenböck G: Transmission of olfactory information between three populations of neurons in the antennal lobe of the fly. Neuron. 36:463–474. 2002. View Article : Google Scholar : PubMed/NCBI
11	Zimprich A, Biskup S, Leitner P, et al: Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 44:601–607. 2004. View Article : Google Scholar : PubMed/NCBI
12	Liu Z, Wang X, Yu Y, et al: A Drosophila model for LRRK2-linked parkinsonism. Proc Natl Acad Sci USA. 105:2693–2698. 2008. View Article : Google Scholar : PubMed/NCBI
13	Choi DC, Chae YJ, Kabaria S, et al: MicroRNA-7 Protects against 1-Methyl-4-Phenylpyridinium-Induced Cell Death by Targeting RelA. J Neuroscience. 34:12725–12737. 2014. View Article : Google Scholar
14	White KE, Humphrey DM and Hirth F: The dopaminergic system in the aging brain of Drosophila. Front Neurosci. 4:2052010. View Article : Google Scholar : PubMed/NCBI
15	Braak H and Del Tredici K: Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology. 70:1916–1925. 2008. View Article : Google Scholar : PubMed/NCBI
16	Obeso JA, Rodriguez-Oroz MC, Goetz CG, et al: Missing pieces in the Parkinson’s disease puzzle. Nat Med. 16:653–661. 2010. View Article : Google Scholar : PubMed/NCBI
17	Friggi-Grelin F, Coulom H, Meller M, Gomez D, Hirsh J and Birman S: Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylase. J Neurobiol. 54:618–627. 2003. View Article : Google Scholar : PubMed/NCBI
18	Ueno K, Naganos S, Hirano Y, Horiuchi J and Saitoe M: Long-term enhancement of synaptic transmission between antennal lobe and mushroom body in cultured Drosophila brain. Physiology. 591:287–302. 2013. View Article : Google Scholar
19	D’Souza RD, Parsa PV and Vijayaraghavan S: Nicotinic receptors modulate olfactory bulb external tufted cells via an excitation-dependent inhibitory mechanism. J Neurophysiology. 110:1544–1553. 2013. View Article : Google Scholar
20	Ran D, Cai S, Wu H and Gu H: Di (2-ethylhexyl) phthalate modulates cholinergic mini-presynaptic transmission of projection neurons in Drosophila antennal lobe. Food Chem Toxicol. 50:3291–3297. 2012. View Article : Google Scholar : PubMed/NCBI
21	Brand AH and Perrimon N: Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 118:401–15. 1993.PubMed/NCBI
22	Gu H and O’Dowd DK: Cholinergic synaptic transmission in adult Drosophila Kenyon cells in situ. J Neurosci. 26:265–272. 2006. View Article : Google Scholar : PubMed/NCBI
23	Gu H and O’Dowd DK: Whole cell recordings from brain of adult Drosophila. J Vis Exp. (6): 2482007.
24	Yan Y, Yang Y, You J, et al: Permethrin modulates cholinergic mini-synaptic currents by partially blocking the calcium channel. Toxicol Lett. 201:258–263. 2011. View Article : Google Scholar : PubMed/NCBI
25	Venderova K, Kabbach G, Abdel-Messih E, et al: Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson’s disease. Hum Mol Genet. 18:4390–4404. 2009. View Article : Google Scholar : PubMed/NCBI
26	Tai Y, Chen L, Huang E, et al: Protective effect of alpha-synuclein knockdown on methamphetamine-induced neurotoxicity in dopaminergic neurons. Neural regeneration research. 9:951–958. 2014. View Article : Google Scholar : PubMed/NCBI Feany MB and Bender WW: A Drosophila model of Parkinson’s disease. Nature. 404:394–398. 2000. View Article : Google Scholar : PubMed/NCBI
27	Dauer W and Przedborski S: Parkinson’s disease: mechanisms and models. Neuron. 39:889–909. 2003. View Article : Google Scholar : PubMed/NCBI
28	Forno LS: Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol. 55:259–272. 1996. View Article : Google Scholar : PubMed/NCBI
29	Mouradian MM: Recent advances in the genetics and pathogenesis of Parkinson disease. Neurology. 58:179–185. 2002. View Article : Google Scholar : PubMed/NCBI
30	Yamasaki M, Hashimoto K and Kano M: Miniature synaptic events elicited by presynaptic Ca²⁺ rise are selectively suppressed by cannabinoid receptor activation in cerebellar Purkinje cells. J Neurosci. 26:86–95. 2006. View Article : Google Scholar : PubMed/NCBI
31	Zhang J, Yang Y, Li H, Cao J and Xu L: Amplitude/frequency of spontaneous mEPSC correlates to the degree of long-term depression in the CA1 region of the hippocampal slice. Brain Res. 1050:110–117. 2005. View Article : Google Scholar : PubMed/NCBI
32	Talantova M, Sanz-Blasco S, Zhang X, et al: Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc Natl Acad Sci USA. 110:E2518–E2527. 2013. View Article : Google Scholar
33	Yasuyama K, Meinertzhagen IA and Schürmann FW: Synaptic organization of the mushroom body calyx in Drosophila melanogaster. J Comp Neurol. 445:211–226. 2002. View Article : Google Scholar : PubMed/NCBI
34	Su H and O’Dowd DK: Fast synaptic currents in Drosophila mushroom body Kenyon cells are mediated by alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors and picrotoxin-sensitive GABA receptors. J Neurosci. 23:9246–9253. 2003.PubMed/NCBI
35	Simkus CR and Stricker C: The contribution of intracellular calcium stores to mEPSCs recorded in layer II neurones of rat barrel cortex. J Physiol. 545:521–535. 2002. View Article : Google Scholar : PubMed/NCBI
36	Kato R, Tachibana K, Nishimoto N, et al: Neonatal exposure to sevoflurane causes significant suppression of hippocampal long-term potentiation in postgrowth rats. Anesth Analg. 117:1429–1435. 2013. View Article : Google Scholar : PubMed/NCBI
37	Shaltiel-Karyo R, Davidi D, Menuchin Y, et al: A novel, sensitive assay for behavioral defects in Parkinson’s disease model Drosophila. Parkinsons Dis. 2012:6975642012.
38	Kwon Y, Kim JW, Ho Y, et al: Analysis of antagonistic co-contractions with motorized passive movement device in patients with parkinson’s disease. Bio-medical materials and engineering. 24:2291–2297. 2014.
39	Oxenkrug GF: The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine. J Neural Transm. 117:23–26. 2010. View Article : Google Scholar
40	Jenner P and Olanow CW: The pathogenesis of cell death in Parkinson’s disease. Neurology. 66:S24–S36. 2006. View Article : Google Scholar : PubMed/NCBI
41	Reynolds NP, Soragni A, Rabe M, et al: Mechanism of membrane interaction and disruption by α-synuclein. J Am Chem Soc. 133:19366–19375. 2011. View Article : Google Scholar : PubMed/NCBI
42	Rajput A, Dickson DW, Robinson CA, et al: Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology. 67:1506–1508. 2006. View Article : Google Scholar : PubMed/NCBI
43	Ross OA, Toft M, Whittle AJ, et al: Lrrk2 and Lewy body disease. Ann Neurol. 59:388–393. 2006. View Article : Google Scholar : PubMed/NCBI